Research reveals an efficient method to synthesize fluorinated isoxazolines for drug development, suggesting a greener pathway to innovative treatments.
Isoxazolines have attracted widespread attention for the development of anticancer, antiviral, and anti‐inflammatory drugs due to their unique electronic properties and conformational rigidity. However, the application of fluorinated isoxazolines in the development of innovative drugs has been constrained by the lack of appropriate synthetic methods for introducing fluorine atoms into the isoxazole ring skeleton. In this article, a rapid synthesis of fluoroisoxazolines is reported based on a pre‐functionalization strategy: ethyl 3‐bromo‐2‐((diphenylmethylene)amino)‐3,3‐difluoropropionate is reacted with imine oxides under alkaline conditions to efficiently construct the fluoroisoxazolidine skeleton in one step without the need for transition metal catalysts. This simple operation is performed under mild green reaction conditions, offering a concise and efficient pathway for the synthesis of fluoroisoxazololidine compounds.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: